Pharmaceutical Technology

JUNE 19, 2023

Novartis and Incyte Corp’s Jakafi was the first FDA-approved drug for the treatment of myelofibrosis in November 2011. First-in-line treatment for myelofibrosis currently involves treatment with Jakafi (ruxolitinib) in combination with other drugs such as danazol.

Food and Drug Administration 98

Food and Drug Administration FDA Prescription Food 98

World of DTC Marketing

MAY 2, 2021

On a percentage basis, the figure for 2020 was Independence’s highest profit margin since 2011, records show. IBC, the Philadelphia region’s largest health insurer , on Tuesday reported 2020 net income of $622 million — almost double its $321 million income in 2019, before COVID-19 struck. The company also did well in the stock market.

Healthcare 277

Healthcare Healthcare Insurance Government 277

European Pharmaceutical Review

AUGUST 23, 2022

To achieve this objective, the regulation amends Directive 2011/24/EU on the application of patients’ rights in cross?border Directive 2011/24/EU had the merit of drawing attention to the need for an appropriate and centralised assessment of health technologies but failed to ensure effective harmonisation on the issue. Lorgelly PK.,

Consulting 98

Consulting Medical Healthcare Healthcare 98

World of DTC Marketing

NOVEMBER 5, 2021

.” 95% of diets fail and most will regain their lost weight in 1-5 years (Source: Statistics on Weight Discrimination: A Waste of Talent , The Council on Size and Weight Discrimination, Retrieved July 18, 2011, from ([link] The “obesity industry” (commercial weight-loss programs, weight-loss drug manufacturers, and bariatric surgery centers ) (..)

Insurance 271

Insurance Side effects Prescription Medical 271

pharmaphorum

JANUARY 25, 2023

BMS’ lawsuit claims that Imjudo (tremelimumab) infringes two patents covering its own CTLA4 drug Yervoy (ipilimumab), which has been on the market since 2011 and is a key component of combination therapies for cancer with BMS’ PD-1 inhibitor Opdivo (nivolumab).

FDA 52

FDA Marketing Sales Pharma 52

Pharmaceutical Technology

APRIL 7, 2023

Makena was approved by the FDA under the accelerated approval pathway in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of spontaneous preterm birth. The decision was made after studies did not prove the effectiveness of the drug in preventing preterm birth.

Food and Drug Administration 95

Food and Drug Administration FDA Pharma Food 95

Pharmaceutical Technology

APRIL 7, 2023

Makena was approved by the FDA under the accelerated approval pathway in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of spontaneous preterm birth. The decision was made after studies did not prove the effectiveness of the drug in preventing preterm birth.

Food and Drug Administration 97

Food and Drug Administration FDA Pharma Food 97

World of DTC Marketing

JANUARY 25, 2022

After a series of abortive attempts to tiptoe into the health business—as with Google’s short-lived platform for personal health data, scrapped in 2011—the technology giants are finally finding their feet.

Healthcare 207

Healthcare Healthcare Prescription Medical 207

Copyright Clearance Center

OCTOBER 1, 2022

When Marybeth left the Copyright Office, we were privileged to welcome her to CCC’s Board where she was a Director for seven years from 2011-2017. She was a global thought and policy leader and a beloved mentor to many generations of copyright professionals and lawyers.

59

59

Pharmaceutical Technology

APRIL 20, 2023

Initially reported in 2011, CircRNA is a naturally occurring class of RNA. Targovax has unveiled plans to rebrand as Circio , reflecting its strategic shift to focus on expediting the development of its innovative circular RNA (circRNA) platform.

Engineering 96

Engineering Leads Medicine Pharmaceutical 96

Pharmaceutical Technology

NOVEMBER 3, 2022

A Quantitative View on Award Criteria in Tenders in the EU5 from 2011 to 2020 , Genane C, Trenti S In-Person and Virtual Poster Session 3 Date: Tuesday 8 November 2022 Poster Session Time: 10:00–13:15 HPR150: P&R Policies and Macro-Trends Pertinent to CGTs: Where Are the Main Barriers and Who Leads the Efforts to a Greater Access?

Pharma 52

Pharma Leads Medical Pharmaceutical 52

Legacy MEDSearch

MAY 3, 2023

Leadership includes Joy Celebre (recruiting since 1996, joined in 2008), Carolyn Jones (recruiting since 1995, joined in 2011), Arshad Alam (recruiting since 1995, joined 2017), John White (Talent Sourcing Manager, joined 2012), and Partner Chris Miclot, (joined 2012). “In

Recruitment 98

Recruitment Medical Management Media 98

World of DTC Marketing

AUGUST 19, 2022

Data from the Kaiser Family Foundation (KFF) shows that between 2011 and 2021, the average premiums for family coverage rose from $15,073 to $22,221—an increase of 47.4%. As the U.S. population health issues increase, the risk of insuring the average American goes up.

Healthcare 204

Healthcare Healthcare Insurance Competition 204

European Pharmaceutical Review

MARCH 7, 2024

He then worked at BCG from 2004 to 2011, where he developed expertise in the energy, engineering, and high-tech sectors. Julien joined Areva in 2011, initially working in the group’s strategy department before taking up the position of Chairman and General Manager of Areva Nuclear Power in China.

Manufacturing 52

Manufacturing Food and Drug Administration Marketing Management 52

Medical Device Success

DECEMBER 18, 2011

I sincerely hope all of you have had a productive and successful 2011. If you have struggled in 2011, let me know, perhaps I can share some ideas for success. The difference between Strategies and Tactics www.medicaldevicesuccess.com/2011/01/04/critical-the-difference-between-strategies-and-tactics/.

Medical 100

Medical Sales Marketing Consulting 100

European Pharmaceutical Review

APRIL 8, 2024

Yet from 2011, these arrangements were the subject of “patent-non- exclusive rights, technology- exclusive rights and technology-supply”. Until 2010, contract manufacturing arrangements were for contract manufacturing (drug-manufacturing/supply) of antibody drugs.

Manufacturing 52

Manufacturing Networking Pharmaceutical Marketing 52

pharmaphorum

JULY 6, 2022

A European Federation of Pharmaceutical Industries and Associations (EFPIA) report published earlier this year, for example, compared the timelines of six regulatory agencies between 2011 and 2020. It found the EMA “lagged behind” most, with a median approval time in 2020 of more than 400 days.

Safety 96

Safety FDA Medicine Patients 96

PM360

JUNE 29, 2022

The line from the 2011 Pixar “Cars” sequel (trust me, as a parent of two, I have seen it countless times) points to the practical implication for voice technology. “Everything is voice activated these days.”

Marketing 96

Marketing Healthcare Provider Prescription Patients 96

Impetus Digital

SEPTEMBER 21, 2022

He started his career in banking and business line management before going through the MBA program at Berkeley in 2011. Marius Rus Founder Marius Rus is a finance and strategy expert turned healthcare entrepreneur.

Consulting 52

Consulting Professional Services Healthcare Provider Healthcare 52

pharmaphorum

DECEMBER 29, 2022

The case revolves around allegations that Novartis made an agreement in 2011 with Par Pharmaceutical when Exforge (valsartan/amlodipine) was nearing the end of its patent life that was designed to keep Par’s generic version of the drug off the market until 30 September, 2014.

Retail 52

Retail Marketing Government Doctors 52

Pharmaceutical Technology

APRIL 27, 2023

Established in 2011, the CDF is a source of funding to increase patient access to cancer drugs in the UK. The UK’s National Institute for Health and Care Excellence (NICE) has recommended two new personalised immunotherapy therapies from Kite Pharma to treat aggressive forms of blood cancer for the Cancer Drugs Fund (CDF).

Patients 59

Patients Medicine Pharma Leads 59

pharmaphorum

AUGUST 8, 2022

In 2011 it paid $340 million for rights to rivipansel , a pan-selectin antagonist developed by GlycoMimetics, which failed a phase 3 test in 2019 and was jettisoned by Pfizer the following year. It’s worth noting that this isn’t Pfizer’s first deal in SCD.

Marketing 105

Marketing Sales Pharma FDA 105

Pharmaceutical Technology

NOVEMBER 14, 2022

In August 2021, Saphnelo, a type 1 interferon receptor antibody, became the first lupus treatment to be approved since GSK’s Benlyta (belimumab) won a regulatory nod in 2011. MSCs and CAR-Ts for lupus. As per AstraZeneca's recent Q3 earnings, Saphnelo has yielded $69 million to date this year.

Side effects 144

Side effects Patients Manufacturing Safety 144

PM360

OCTOBER 25, 2022

The digital health sector has grown significantly during the past decade, with $2 billion invested in 2011 and $44 billion in 2021 by the global financial and corporate markets. In the shadow of the pandemic, tremendous investment poured into digital health. But in the past year, investors have been more selective in their decisions.

Marketing 98

Marketing Leads Healthcare Healthcare 98

pharmaphorum

OCTOBER 9, 2022

Chowiria was previously chairman and CBO at Nektar 2011 when it was trying to build a business in respiratory therapeutics including a now-defunct inhaled formulation of insulin. One link between the two companies lies in PureTech’s president and chief business officer Bharat Chowiria, note analysts at Mizuho.

Leads 57

Leads Healthcare Healthcare 57

World of DTC Marketing

FEBRUARY 4, 2021

regulators knew about reports of suicidal behavior in men taking the anti-baldness treatment Propecia when they decided not to warn consumers of those potential risks in a 2011 update of the popular drug’s label. Newly unsealed court documents show that Merck and U.S. Annual U.S.

Pharma 180

Pharma Food and Drug Administration Side effects Safety 180

PM360

NOVEMBER 14, 2023

Since 2011, GoodRx has helped consumers save over $60 billion and is one of the most trusted digital health brands by both patients and providers and downloaded medical apps over the past decade.

Retail 52

Retail Pharmaceutical manufacturing Sales Insurance 52

European Pharmaceutical Review

JANUARY 29, 2024

2011 Dec;12(4):1248-63. 2011; 8(4): 330-345. Accessed 14 January 2024. Wu Y, Levons J, Narang AS, et al. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility. AAPS PharmSciTech. Accelerating Drug Development. Eur Pharm Rev. 2023; 28(1): 5. Ghadanian M, Schafheutle E. 11/27/23.

Pharmaceutical 104

Pharmaceutical Food and Drug Administration Medicine FDA 104

Medical Device Success

NOVEMBER 17, 2010

Then I ask you, “Do you have a formal written plan that articulates the strategies and tactics you will follow in 2011?” Write down the fact you will make a strategic plan for 2011 or the next 6 months…whatever. If you are driving a car, you know that it will take less time to follow the path of A to E and it will cost less in fuel.

Sales 100

Sales Medical Marketing Consulting 100

PM360

OCTOBER 24, 2022

Through the GoodRx App, savings cards, and their website, GoodRx has saved Americans over $35 billion on prescriptions and avoid $60 million in hospitalization costs since 2011. Innovation.

Prescription 40

Prescription Insurance Healthcare Healthcare 40

Map My Customers

SEPTEMBER 13, 2022

The 2011 book The Challenger Sale by Brent Adamson and Matthew Dixon suggested that the way to charge ahead is to take on the persona of a “challenger,” challenging both conventional sales approaches and your prospect in sales calls. But experienced reps know that even the hardest objections in sales can be overcome.

Sales 70

Sales Prospecting Sales presentations Sales process 70

Pharmaceutical Technology

SEPTEMBER 13, 2022

Since the approval of the first ICI – Bristol-Myers Squibb's (BMS) Yervoy (ipilimumab) in 2011 for unresectable metastatic melanoma – multiple checkpoint inhibitors have been approved in this disease setting. More recently, ICIs have also been approved for resectable cutaneous melanomas as adjuvant therapy, following surgical resection.

Patients 69

Patients Physicians Safety Pharma 69

Pharma Marketing Network

MARCH 25, 2022

February 2019. Accessed March 12, 2022. National Alliance for Caregiving. Public Health. Accessed March 15, 2022. American Psychological Association. Caregiving Facts. Accessed February 28, 2022. Centers for Disease Control and Prevention. Caregiving for family and friends — a public health issue. Accessed March 12, 2022.

Pharma 98

Pharma Education Training Transportation 98

pharmaphorum

NOVEMBER 25, 2022

He became CEO in 2011, as the company moved from purely consulting to developing forecast models, and has continued to evolve the business, using innovative technology to drive efficiencies for clients’ processes. About the author. David James has a long history within global product forecasting and consulting and co-launched J+D in 2005.

Marketing 117

Marketing Consulting Patients Sales 117

Healthcare Success

JANUARY 25, 2023

The rate of injuries from violent attacks against medical professionals grew by 63% from 2011 to 2018. To be clear, workplace violence experienced by healthcare workers predates the pandemic. However, these numbers escalated in 2020, along with the COVID-19 pandemic. Why are people so angry and rude? How did we get here?

Patients 108

Patients Healthcare Healthcare Management 108

Legacy MEDSearch

JANUARY 13, 2023

Headquartered in Boca Raton, Florida, Hip Innovation Technology was formed in 2011 to provide market-leading orthopedic device solutions that advance the quality of life and quality of care for patients. About Hip Innovation Technology, LLC.

FDA 98

FDA Safety Recruitment Patients 98

pharmaphorum

FEBRUARY 23, 2016

According to the European Commission and NIHR Clinical Research Network, between 2007 and 2011, delays for launching clinical trials rose by 90%. And with approximately one third of the clinical trial timeline spent in patient recruitment, delays in launching clinical trials will increase costs and drain resources.

Patients 52

Patients Recruitment Media Management 52